CompletedNot Applicable

Exploratory Investigation on a Novel Catheter

Netherlands13 participantsStarted 2022-11-18

Plain-language summary

An exploratory, pre-market, open, prospective, interventional, clinical investigation at a limited number of centers for proof of concept of a new catheter. In this proof of concept investigation, subjects experienced in using transanal irrigation (TAI) with a balloon catheter will be using study catheters at two occasions to primarily study if the catheter will stay in place during the water instillation when performing TAI. Each subject will be followed during approximately one week, depending on the usual time between their TAI.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Provision of informed consent.
✓. Female and male aged 18-80 years.
✓. Patients successfully treated by TAI with Navina Smart system for at least 3 months and/or stable in therapy.
✓. Patients considered suitable to participate by investigator.
✓. Able to read, write and understand information given to them regarding the study.

Exclusion criteria

✕. Involvement in the planning and conduct of the clinical investigation (applies to both Wellspect HealthCare staff and staff at the study site).
✕. Previous enrolment in the present clinical investigation.
✕. Simultaneous participation in another clinical investigation, or participation in a clinical investigation during the last month, that may interfere with the present clinical investigation.
✕. Severe non-compliance to Clinical Investigation Plan as judged by the investigator and/or Wellspect HealthCare.
✕. Significant cardiovascular and/or other significant co-morbidities which could be negatively affected by the use of the investigational product.
✕. Known anal or colorectal stenosis.
✕. Active inflammatory bowel disease.

What they're measuring

Catheter stay in place

Timeframe: 1 week

Trial details

NCT IDNCT05644912

SponsorWellspect HealthCare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-12-15

View on ClinicalTrials.gov More Bowel Dysfunction trials